PHX Pharmx Technologies Limited
Healthcare · Health Information Services
· website
$0.10
52wk 0.08 – 0.20
Overall
43.3
Value
72.9
Growth
32.6
Health
75.5
Quality
0.0
Momentum
18.4
Dividend
—
Price
About Pharmx Technologies Limited
Pharmx Technologies Limited, together with its subsidiaries, engages in the technology and software development business in Australia and New Zealand. It offers Pharmx Gateway, an electronic ordering and invoicing solution; Pharmx Marketplace, an e-commerce ordering platform; and Pharmx Analytics, a solution that provides insights for suppliers and buyers. The company was formerly known as Corum Group Limited and changed its name to Pharmx Technologies Limited in October 2023. Pharmx Technologies Limited was incorporated in 1950 and is based in Sydney, Australia.
Price analytics
Returns
| 1 day | 0.0% |
| 1 week | -3.0% |
| 1 month | 9.1% |
| 3 months | -12.7% |
| 6 months | -16.5% |
| 1 year | -26.2% |
| 3 years | 118.2% |
Risk
| Volatility (1y ann.) | 85.9% |
| Beta vs ASX 200 | 0.28 |
| Sharpe (1y) | 0.01 |
| VaR 95% (1-day) | -8.3% |
| Max drawdown (1y) | -51.8% |
| Off 1-year high | -43.5% |
Technicals
| RSI(14) | 61 |
| vs 50DMA | -0.4% |
| vs 200DMA | -17.1% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
72.9
Trailing P/E
—
Forward P/E
—
PEG ratio
81
EV / EBITDA
100
Price / Book
73
Price / Sales
17
Growth
32.6
Revenue growth (1y)
65
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
75.5
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
0
Current ratio
90
Debt / Equity
100
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
18.4
6-month return vs ASX 200
17
Price vs 200-day average
0
Price vs 50-day average
48
Position in 52-week range
13
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$64.19M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
0.33
EV / EBITDA
-35.42
Price / Book
2.74
ROE
-9.3%
Operating margin
-36.1%
Net margin
-24.0%
Total cash
$2.57M
Total debt
$540,000
Current ratio
2.33
Debt / Equity
0.02
Free cash flow
$-2.28M
Avg volume
225,712
Latest annual results
(FY ending 30 Jun 2025)
- Revenue$7.32M
- Gross profit$5.96M
- Operating income-$1.42M
- Net income-$264.00K
- Diluted EPS-0.00
- Free cash flow-$9.88M
- Net debt-$3.28M